| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quercus | 8 | 2025 | 9 | 3.390 |
Why?
|
| Plant Diseases | 6 | 2020 | 61 | 3.370 |
Why?
|
| Enterobacteriaceae | 9 | 2020 | 29 | 3.320 |
Why?
|
| Cellulose | 5 | 2025 | 23 | 2.160 |
Why?
|
| Trees | 4 | 2025 | 21 | 1.960 |
Why?
|
| RNA, Ribosomal, 16S | 14 | 2025 | 190 | 1.860 |
Why?
|
| DNA, Bacterial | 9 | 2025 | 207 | 1.730 |
Why?
|
| Phylogeny | 10 | 2025 | 740 | 1.440 |
Why?
|
| Bacteria | 6 | 2025 | 285 | 1.420 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 246 | 1.350 |
Why?
|
| Fibrobacter | 4 | 2012 | 4 | 1.340 |
Why?
|
| Gammaproteobacteria | 2 | 2020 | 7 | 1.320 |
Why?
|
| Genome, Bacterial | 4 | 2025 | 132 | 1.310 |
Why?
|
| Environmental Microbiology | 3 | 2014 | 27 | 1.250 |
Why?
|
| Bioreactors | 3 | 2025 | 29 | 1.190 |
Why?
|
| Feces | 7 | 2020 | 126 | 1.170 |
Why?
|
| Rahnella | 2 | 2019 | 3 | 1.160 |
Why?
|
| Soil Microbiology | 4 | 2020 | 67 | 1.130 |
Why?
|
| Radiology | 3 | 2017 | 12 | 1.090 |
Why?
|
| Shellfish | 6 | 2024 | 14 | 1.080 |
Why?
|
| Sewage | 6 | 2025 | 27 | 1.080 |
Why?
|
| Positron-Emission Tomography | 4 | 2017 | 93 | 1.050 |
Why?
|
| Water Microbiology | 7 | 2024 | 82 | 1.030 |
Why?
|
| Nuclear Medicine | 2 | 2017 | 4 | 0.980 |
Why?
|
| Fungi | 4 | 2016 | 103 | 0.970 |
Why?
|
| Fresh Water | 4 | 2016 | 48 | 0.960 |
Why?
|
| Environmental Monitoring | 6 | 2024 | 226 | 0.930 |
Why?
|
| Genomics | 2 | 2018 | 289 | 0.920 |
Why?
|
| Bacteroidetes | 1 | 2025 | 13 | 0.920 |
Why?
|
| Multiple Myeloma | 4 | 2018 | 45 | 0.900 |
Why?
|
| Xylans | 1 | 2025 | 26 | 0.880 |
Why?
|
| Safety | 2 | 2014 | 51 | 0.830 |
Why?
|
| Refuse Disposal | 4 | 2012 | 17 | 0.820 |
Why?
|
| Geologic Sediments | 5 | 2019 | 47 | 0.810 |
Why?
|
| Lactobacillales | 1 | 2023 | 2 | 0.800 |
Why?
|
| Ecology | 3 | 2020 | 33 | 0.800 |
Why?
|
| Sequence Analysis, DNA | 8 | 2025 | 508 | 0.780 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2018 | 16 | 0.720 |
Why?
|
| Food Contamination | 4 | 2017 | 55 | 0.720 |
Why?
|
| Veterans | 1 | 2022 | 203 | 0.660 |
Why?
|
| Rain | 1 | 2020 | 10 | 0.650 |
Why?
|
| Polymerase Chain Reaction | 6 | 2017 | 454 | 0.600 |
Why?
|
| Radiopharmaceuticals | 2 | 2016 | 62 | 0.600 |
Why?
|
| Enterovirus | 4 | 2020 | 11 | 0.600 |
Why?
|
| RNA, Bacterial | 2 | 2016 | 38 | 0.570 |
Why?
|
| Escherichia coli | 5 | 2024 | 461 | 0.530 |
Why?
|
| Humans | 44 | 2022 | 42163 | 0.530 |
Why?
|
| Ecosystem | 4 | 2025 | 171 | 0.520 |
Why?
|
| Virulence Factors | 1 | 2018 | 119 | 0.520 |
Why?
|
| Pseudomonadaceae | 1 | 2016 | 2 | 0.510 |
Why?
|
| Internship and Residency | 2 | 2015 | 141 | 0.500 |
Why?
|
| Neuroendocrine Cells | 1 | 2016 | 4 | 0.500 |
Why?
|
| Animals | 26 | 2025 | 16695 | 0.490 |
Why?
|
| Somatostatin | 1 | 2016 | 20 | 0.490 |
Why?
|
| Hyperplasia | 1 | 2016 | 39 | 0.490 |
Why?
|
| Radiation Dosage | 2 | 2014 | 37 | 0.490 |
Why?
|
| Mouth | 1 | 2016 | 49 | 0.490 |
Why?
|
| Anaerobiosis | 3 | 2025 | 17 | 0.490 |
Why?
|
| Bacterial Typing Techniques | 3 | 2025 | 36 | 0.480 |
Why?
|
| Lung Diseases | 1 | 2016 | 62 | 0.460 |
Why?
|
| Fibroblasts | 2 | 2014 | 278 | 0.450 |
Why?
|
| Internal Medicine | 1 | 2014 | 32 | 0.440 |
Why?
|
| Certification | 1 | 2014 | 21 | 0.440 |
Why?
|
| Radiation Injuries | 1 | 2014 | 23 | 0.430 |
Why?
|
| Ichthyosis | 1 | 2014 | 4 | 0.430 |
Why?
|
| Acantholysis | 1 | 2014 | 2 | 0.430 |
Why?
|
| Base Composition | 2 | 2025 | 25 | 0.430 |
Why?
|
| Chromosomes | 1 | 2014 | 44 | 0.420 |
Why?
|
| Computers | 1 | 2013 | 35 | 0.420 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 36 | 0.410 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 78 | 0.410 |
Why?
|
| Radioactive Hazard Release | 1 | 2013 | 6 | 0.410 |
Why?
|
| Shiga Toxin | 2 | 2010 | 5 | 0.410 |
Why?
|
| Physician's Role | 1 | 2013 | 39 | 0.400 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 57 | 0.400 |
Why?
|
| Fatty Acids | 2 | 2025 | 134 | 0.400 |
Why?
|
| Mitosis | 1 | 2014 | 112 | 0.400 |
Why?
|
| Prostate | 1 | 2014 | 152 | 0.390 |
Why?
|
| Bacteria, Anaerobic | 3 | 2023 | 11 | 0.390 |
Why?
|
| Disaster Planning | 1 | 2013 | 58 | 0.380 |
Why?
|
| Microbiological Techniques | 1 | 2012 | 13 | 0.370 |
Why?
|
| Down-Regulation | 1 | 2014 | 452 | 0.370 |
Why?
|
| Software | 1 | 2013 | 234 | 0.360 |
Why?
|
| Decision Making | 1 | 2014 | 242 | 0.360 |
Why?
|
| Genetic Variation | 1 | 2014 | 429 | 0.360 |
Why?
|
| RNA, Ribosomal, 18S | 2 | 2017 | 10 | 0.360 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 250 | 0.360 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 67 | 0.350 |
Why?
|
| Radiation, Ionizing | 3 | 2019 | 13 | 0.350 |
Why?
|
| Response Elements | 1 | 2010 | 55 | 0.330 |
Why?
|
| Prophages | 1 | 2010 | 4 | 0.330 |
Why?
|
| Coliphages | 1 | 2010 | 9 | 0.330 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2010 | 5 | 0.330 |
Why?
|
| Virus Activation | 1 | 2010 | 38 | 0.320 |
Why?
|
| Dominance, Ocular | 1 | 2009 | 1 | 0.320 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2009 | 14 | 0.310 |
Why?
|
| Trans-Activators | 1 | 2010 | 190 | 0.310 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2010 | 89 | 0.310 |
Why?
|
| Sheep | 4 | 2016 | 77 | 0.300 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 518 | 0.300 |
Why?
|
| Visual Perception | 1 | 2009 | 75 | 0.300 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 599 | 0.270 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1679 | 0.270 |
Why?
|
| Wales | 4 | 2024 | 5 | 0.260 |
Why?
|
| Norovirus | 2 | 2017 | 15 | 0.260 |
Why?
|
| Antioxidants | 1 | 2010 | 439 | 0.260 |
Why?
|
| Metagenomics | 3 | 2017 | 43 | 0.250 |
Why?
|
| Rivers | 3 | 2024 | 50 | 0.250 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 1559 | 0.240 |
Why?
|
| Prognosis | 3 | 2018 | 850 | 0.240 |
Why?
|
| Middle Aged | 8 | 2018 | 11819 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 114 | 0.240 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 683 | 0.230 |
Why?
|
| Methane | 1 | 2025 | 10 | 0.230 |
Why?
|
| Crassostrea | 1 | 2024 | 4 | 0.230 |
Why?
|
| Carbon Dioxide | 1 | 2025 | 86 | 0.230 |
Why?
|
| Radiation Protection | 1 | 2004 | 5 | 0.230 |
Why?
|
| Equipment Failure | 1 | 2004 | 12 | 0.230 |
Why?
|
| Radiometry | 1 | 2004 | 8 | 0.230 |
Why?
|
| Radioactive Fallout | 1 | 2004 | 3 | 0.230 |
Why?
|
| Gamma Rays | 1 | 2004 | 27 | 0.230 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 45 | 0.230 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 2004 | 1 | 0.220 |
Why?
|
| Ketorolac Tromethamine | 1 | 2004 | 1 | 0.220 |
Why?
|
| Hyperopia | 1 | 2004 | 7 | 0.220 |
Why?
|
| Amino Acids | 1 | 2025 | 150 | 0.220 |
Why?
|
| Salmonella | 2 | 2014 | 12 | 0.210 |
Why?
|
| Seasons | 3 | 2019 | 133 | 0.210 |
Why?
|
| DNA, Ribosomal | 3 | 2014 | 39 | 0.210 |
Why?
|
| Cluster Analysis | 3 | 2017 | 206 | 0.210 |
Why?
|
| DNA Primers | 4 | 2013 | 295 | 0.200 |
Why?
|
| Pyruvates | 1 | 2023 | 6 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 147 | 0.200 |
Why?
|
| Glycerol | 1 | 2023 | 34 | 0.200 |
Why?
|
| Algorithms | 2 | 2017 | 508 | 0.190 |
Why?
|
| Biodegradation, Environmental | 2 | 2013 | 82 | 0.190 |
Why?
|
| Isoptera | 2 | 2012 | 5 | 0.190 |
Why?
|
| Mytilus edulis | 2 | 2024 | 2 | 0.190 |
Why?
|
| England | 2 | 2024 | 11 | 0.190 |
Why?
|
| Male | 14 | 2019 | 22779 | 0.180 |
Why?
|
| Female | 11 | 2018 | 24018 | 0.180 |
Why?
|
| Water Pollution | 2 | 2019 | 13 | 0.180 |
Why?
|
| Carbon | 2 | 2025 | 127 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 649 | 0.170 |
Why?
|
| Viruses | 1 | 2021 | 39 | 0.170 |
Why?
|
| Rumen | 2 | 2012 | 6 | 0.170 |
Why?
|
| Clostridium | 2 | 2012 | 24 | 0.170 |
Why?
|
| Soil | 2 | 2025 | 170 | 0.170 |
Why?
|
| Metagenome | 2 | 2017 | 31 | 0.170 |
Why?
|
| beta-Lactamases | 1 | 2020 | 34 | 0.170 |
Why?
|
| DNA Replication | 2 | 2014 | 153 | 0.170 |
Why?
|
| Glioma | 2 | 2012 | 92 | 0.160 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 94 | 0.160 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 116 | 0.160 |
Why?
|
| Microbial Viability | 1 | 2020 | 42 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 51 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 309 | 0.160 |
Why?
|
| Plants | 1 | 2020 | 114 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 196 | 0.160 |
Why?
|
| Arkansas | 3 | 2015 | 43 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2019 | 6 | 0.150 |
Why?
|
| Species Specificity | 1 | 2020 | 279 | 0.150 |
Why?
|
| Space Flight | 1 | 2019 | 18 | 0.150 |
Why?
|
| Visual Acuity | 3 | 2012 | 117 | 0.150 |
Why?
|
| Adenoviruses, Human | 1 | 2018 | 4 | 0.150 |
Why?
|
| Cardiovascular System | 1 | 2019 | 37 | 0.150 |
Why?
|
| Spleen | 2 | 2017 | 199 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 18 | 0.140 |
Why?
|
| Water Purification | 1 | 2018 | 33 | 0.140 |
Why?
|
| Temperature | 2 | 2021 | 314 | 0.140 |
Why?
|
| Waste Disposal, Fluid | 1 | 2018 | 19 | 0.140 |
Why?
|
| Genome, Plant | 1 | 2017 | 29 | 0.140 |
Why?
|
| Systems Biology | 1 | 2017 | 26 | 0.140 |
Why?
|
| Necrosis | 1 | 2017 | 54 | 0.140 |
Why?
|
| Droughts | 1 | 2017 | 29 | 0.130 |
Why?
|
| Enterovirus Infections | 1 | 2017 | 4 | 0.130 |
Why?
|
| Hexokinase | 1 | 2017 | 10 | 0.130 |
Why?
|
| Caliciviridae Infections | 1 | 2017 | 8 | 0.130 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2017 | 13 | 0.130 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 21 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 173 | 0.130 |
Why?
|
| DNA Gyrase | 1 | 2016 | 7 | 0.130 |
Why?
|
| Medicine | 1 | 2017 | 37 | 0.130 |
Why?
|
| Biodiversity | 1 | 2017 | 109 | 0.130 |
Why?
|
| Communicable Diseases | 1 | 2017 | 47 | 0.130 |
Why?
|
| DNA, Fungal | 1 | 2016 | 47 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 1804 | 0.130 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2013 | 6 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 57 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 167 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 79 | 0.120 |
Why?
|
| Enterococcus | 1 | 2016 | 8 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 71 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 203 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 2 | 2010 | 415 | 0.120 |
Why?
|
| Fund Raising | 1 | 2015 | 1 | 0.120 |
Why?
|
| Aged | 3 | 2018 | 7982 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 933 | 0.120 |
Why?
|
| Bronchi | 1 | 2016 | 45 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 602 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 89 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 366 | 0.120 |
Why?
|
| Dogs | 1 | 2016 | 201 | 0.120 |
Why?
|
| Proteomics | 1 | 2018 | 363 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 299 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 61 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2015 | 2111 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 228 | 0.110 |
Why?
|
| Mice | 8 | 2015 | 6490 | 0.110 |
Why?
|
| Salinity | 1 | 2014 | 18 | 0.110 |
Why?
|
| Diagnosis-Related Groups | 1 | 2014 | 12 | 0.110 |
Why?
|
| Flocculation | 1 | 2014 | 6 | 0.110 |
Why?
|
| Water Pollutants | 1 | 2014 | 18 | 0.110 |
Why?
|
| Registries | 1 | 2017 | 431 | 0.110 |
Why?
|
| Biotransformation | 1 | 2014 | 68 | 0.110 |
Why?
|
| Recreation | 1 | 2014 | 42 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 12 | 0.110 |
Why?
|
| Base Sequence | 3 | 2013 | 997 | 0.110 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 39 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1420 | 0.110 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2013 | 10 | 0.110 |
Why?
|
| Whole-Body Irradiation | 2 | 2010 | 9 | 0.110 |
Why?
|
| Quality Control | 1 | 2013 | 41 | 0.100 |
Why?
|
| Mice, Inbred C3H | 2 | 2010 | 80 | 0.100 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 96 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1066 | 0.100 |
Why?
|
| Particle Size | 1 | 2014 | 267 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 2803 | 0.100 |
Why?
|
| Escherichia coli O157 | 1 | 2013 | 17 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 580 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2017 | 884 | 0.100 |
Why?
|
| Cell Survival | 2 | 2014 | 934 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 310 | 0.100 |
Why?
|
| Lung | 1 | 2016 | 484 | 0.100 |
Why?
|
| Enterococcus faecalis | 1 | 2013 | 44 | 0.100 |
Why?
|
| Meibomian Glands | 1 | 2012 | 2 | 0.100 |
Why?
|
| Eyelid Diseases | 1 | 2012 | 5 | 0.090 |
Why?
|
| Dry Eye Syndromes | 1 | 2012 | 5 | 0.090 |
Why?
|
| Micromonospora | 1 | 2012 | 2 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 348 | 0.090 |
Why?
|
| Cellulases | 1 | 2012 | 2 | 0.090 |
Why?
|
| Cellulase | 1 | 2012 | 3 | 0.090 |
Why?
|
| Waste Products | 1 | 2012 | 5 | 0.090 |
Why?
|
| Bacteria, Aerobic | 1 | 2012 | 7 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2012 | 67 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 27 | 0.090 |
Why?
|
| Enzyme Assays | 1 | 2012 | 13 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2012 | 88 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2012 | 34 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 379 | 0.090 |
Why?
|
| United States | 1 | 2022 | 5072 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 421 | 0.090 |
Why?
|
| Communication | 1 | 2013 | 207 | 0.090 |
Why?
|
| Cattle | 2 | 2010 | 505 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 129 | 0.090 |
Why?
|
| Mammals | 1 | 2012 | 109 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 174 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 151 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 501 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2010 | 52 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 111 | 0.080 |
Why?
|
| Luciferases | 1 | 2010 | 70 | 0.080 |
Why?
|
| Norfloxacin | 1 | 2010 | 1 | 0.080 |
Why?
|
| Bacteriophage lambda | 1 | 2010 | 11 | 0.080 |
Why?
|
| RNA, Archaeal | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tetracyclines | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 2009 | 8 | 0.080 |
Why?
|
| DNA Probes | 1 | 2009 | 33 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 158 | 0.080 |
Why?
|
| Risk Factors | 2 | 2018 | 3942 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 14 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2019 | 990 | 0.080 |
Why?
|
| Vision, Binocular | 1 | 2009 | 8 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 764 | 0.080 |
Why?
|
| Contrast Sensitivity | 1 | 2009 | 35 | 0.080 |
Why?
|
| Ornithine Decarboxylase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3077 | 0.070 |
Why?
|
| Age Factors | 3 | 2017 | 1139 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2010 | 196 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 207 | 0.070 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2008 | 4 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 115 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2008 | 26 | 0.070 |
Why?
|
| Adult | 5 | 2018 | 13458 | 0.070 |
Why?
|
| Water Pollutants, Chemical | 1 | 2009 | 170 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1010 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 318 | 0.070 |
Why?
|
| Neoplasms | 2 | 2015 | 1341 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 185 | 0.060 |
Why?
|
| HIV-1 | 1 | 2012 | 747 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1265 | 0.060 |
Why?
|
| Food Chain | 1 | 2025 | 20 | 0.060 |
Why?
|
| Photosynthesis | 1 | 2025 | 34 | 0.060 |
Why?
|
| Fermentation | 1 | 2025 | 38 | 0.060 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2004 | 4 | 0.060 |
Why?
|
| Photorefractive Keratectomy | 1 | 2004 | 6 | 0.060 |
Why?
|
| Lasers, Excimer | 1 | 2004 | 7 | 0.060 |
Why?
|
| Nitrogen | 1 | 2025 | 83 | 0.050 |
Why?
|
| Equipment Design | 1 | 2004 | 143 | 0.050 |
Why?
|
| Cornea | 1 | 2004 | 81 | 0.050 |
Why?
|
| Technology Transfer | 1 | 2003 | 2 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 13 | 0.050 |
Why?
|
| Public Health | 2 | 2018 | 405 | 0.050 |
Why?
|
| Disease Progression | 2 | 2015 | 661 | 0.050 |
Why?
|
| Adolescent | 2 | 2012 | 5950 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2021 | 44 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 1058 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 38 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 1586 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 2598 | 0.040 |
Why?
|
| Diarrhea | 1 | 2020 | 95 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 317 | 0.040 |
Why?
|
| Cosmic Radiation | 1 | 2019 | 5 | 0.040 |
Why?
|
| Bivalvia | 1 | 2019 | 25 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 15 | 0.040 |
Why?
|
| Protons | 1 | 2019 | 94 | 0.040 |
Why?
|
| HIV Infections | 1 | 2012 | 2535 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2004 | 2485 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 27 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 1848 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 353 | 0.030 |
Why?
|
| Genomic Library | 1 | 2017 | 7 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 35 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 87 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 362 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 92 | 0.030 |
Why?
|
| Environment | 1 | 2017 | 148 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 90 | 0.030 |
Why?
|
| Gift Giving | 1 | 2015 | 4 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 796 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 845 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1617 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 237 | 0.030 |
Why?
|
| Bystander Effect | 1 | 2014 | 15 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 22 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 324 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 18 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 54 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 358 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 81 | 0.030 |
Why?
|
| Histones | 1 | 2014 | 194 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 387 | 0.020 |
Why?
|
| Oregon | 1 | 2012 | 64 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2012 | 21 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 35 | 0.020 |
Why?
|
| Cell Division | 1 | 2012 | 314 | 0.020 |
Why?
|
| Gene Library | 1 | 2012 | 60 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 112 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2012 | 133 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2010 | 19 | 0.020 |
Why?
|
| Operon | 1 | 2010 | 43 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 266 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 122 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 711 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 94 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2009 | 124 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 98 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 594 | 0.020 |
Why?
|
| Deoxyribonucleotides | 1 | 2008 | 11 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2012 | 475 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 403 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 1574 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1597 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2008 | 60 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 282 | 0.020 |
Why?
|
| Research Design | 1 | 2009 | 370 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 928 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 774 | 0.020 |
Why?
|
| Mitochondria | 1 | 2008 | 516 | 0.010 |
Why?
|
| Technology, High-Cost | 1 | 2003 | 1 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3701 | 0.010 |
Why?
|